FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Peptides Lack Reliable Safety Information, Watchdog Warns FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157: Miracle Healing Peptide or Hidden Danger?